Merrion Pharmaceuticals announces liquidation plan

Company could have around €4.5m to distribute to shareholders

22nd August, 2016
Dr John Fox to leave Merrion Pharmaceuticals after EGM. PIcture: Feargal Ward

The board of Dublin-listed Merrion Pharmaceuticals has proposed that the company be wound up, with its remaining funds distributed to shareholders.

In a statement today, however, Merrion said its board had looked at a number of investment proposals, none of which were thought "sufficiently compelling" to recommend to shareholders.

The board said a statutory declaration of solvency for the company indicated that around €4.5m was available to shareholders from the proposed liquidation, though this figure...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

EY reports €393m revenues in Republic of Ireland for 2021 financial year

Content is king – just ask Netflix as rivals attempt to steal its crown

Tom Maguire: Tax changes we make now could help business for years